Conferences and Events

2007 Managed Care Conference and Trade Show
October 16, 17, 18 of 2007

<-- Back to the Speakers Page

  Harold C. Urschel III, MD, MMA

Founder and CEO, the Urschel Recovery Science Institute
Chief of Medical Strategy, EnterHealth Global LLC.

The primary goal of Dr. Urschel’s Recovery Science institute as well as his addiction treatment internet site (www.EnterHealth.com) is to combine the best behavioral treatment methods with the latest scientifically proven medications to maximize his patients’ chances of a successful recovery from the life threatening, chronic medical disease of addiction.
Web Address:  www.recovery-science.com
Email:  urschel@recovery-science.com

Dr. Harold C. Urschel, III is CEO /Founder of the Urschel Recovery Science Institute in Dallas, Texas.  Dr. Urschel graduated from Princeton University, U.T. Southwestern Medical School, and The University of Pennsylvania for his undergraduate and medical training.  Dr. Urschel also graduated from Stanford University Graduate School of Business with a Masters Management Administration.  Dr. Urschel is currently board certified in both addiction and general psychiatry.

Since 1998, Dr. Urschel has been implementing the Recovery Science program at two area hospitals in North Texas. Because of Dr. Urschel’s success in bringing the latest breakthroughs in addiction treatment research into his clinical treatment programs, his Recovery Science addiction treatment program has been utilized as the clinical addiction treatment program for the UT Southwestern Medical School, Department of Psychiatry.

Dr. Urschel is also a founder of CNS Research Group, LLP, located in Dallas, Texas, which provides clinical research services for clinical trials in most areas within addiction and general psychiatry.  As a Principal Investigator in clinical research trials, he has participated in numerous major clinical research, multi-site trials in the area of general psychiatric research. As well as advanced psychopharmacological research on drugs targeted at addiction recovery.

He has several clinical research publications including:

• “How Effective is Substance Abuse Treatment – Compared to What?” in Addictive States,
• “Neurological Consequences of Drug Abuse” in Diseases of the Nervous System
• “The Many Paths to Drug Dependence” in Vulnerability to Drug Abuse
• “Alcohol Idiosyncratic Intoxication- A Review of the Data Supporting It’s Existence” in DSM-IV Sourcebook
• “A pilot trial of gepirone versus placebo in the treatment of cocaine dependency” in Psychopharmacology Bulletin
• “Substance Use Disorders” in Manual of Psychiatric Disorders
• “Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative cocaine treatment study” in the Archives of General Psychiatry,
• “The National Institute on Drug Abuse Collaborative cocaine treatment study: Rationale and methods “in the Archives of General Psychiatry, and “Naltrexone Depot for Treatment of Alcohol Dependence: A Multi-Center, Randomized, and Placebo Controlled Clinical Trial”in press.

Prometa article from the Mayo Clinic Journal

download presentation

<-- Back to the Speakers Page